BioSpace News Archive

Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence

On August 31, 2022, Venus Medtech Inc., a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced its interim results for the six months ended June 30, 2022.

September 1, 2022
·
5 min read
Drug Development

Aston Sci. Receives IND Approval from FDA for Phase 2 Clinical Trial of Therapeutic Cancer Vaccine AST-301 in Patients with TNBC

Aston Sci. Inc., a clinical stage biopharmaceutical company specializing in clinical development of therapeutic cancer vaccines, announced that it obtained IND approval from the U.S. Food and Drug Administration (FDA) for Phase 2 clinical trial of its main product, AST-301 (HER2-ICD vaccine).

September 1, 2022
·
3 min read
Business

ICARE HEALTH SOLUTIONS ANNOUNCES STEPHEN KENDIG AS NEW CHIEF OPERATING OFFICER

iCare Health Solutions, a VSP Vision™ company, announced Stephen Kendig as its new Chief Operating Officer.

September 1, 2022
·
1 min read
Biotech Beach

Vanderbilt Completes Study Evaluating Advanced, Four-Dimensional Lung Imaging Software from 4DMedical

4DMedical, the leading developer of functional imaging software for respiratory illness, announced successful completion of a study by Vanderbilt University Medical Center of post-deployment veterans referred by the Nashville VA.

September 1, 2022
·
4 min read
Business

Element Biosciences Welcomes Former ThermoFisher Executive Shelly Peariso to their Growing Commercial Team

Element Biosciences, Inc. announced they are adding an industry veteran to their commercial team.

September 1, 2022
·
2 min read
Biotech Beach

Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® Flu Molecular Test

Cue Health (“Cue”) (Nasdaq: HLTH) today announced that it has made a de novo submission to the U.S. Food and Drug Administration (FDA) for full clearance of the Cue® Flu Molecular Test for at-home and point-of-care (POC) use.

September 1, 2022
·
4 min read
Deals

Cadence Completes Acquisition of OpenEye Scientific

Cadence Design Systems, Inc. (Nasdaq: CDNS) announced today that it has completed the acquisition of OpenEye Scientific Software, Inc. (“OpenEye”).

September 1, 2022
·
4 min read
Business

Biocytogen Lists on the Main Board of HKEX, Aiming to Become the Headstream of New Drugs

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced the company’s official listing on the Main Board of the Stock Exchange of Hong Kong.

September 1, 2022
·
5 min read
Business

Thryv Therapeutics Inc. Announces the Appointment of Dr. Debra Odink to President and Dr. Shi Yin Foo to the Board of Directors

Thryv Therapeutics Inc. is pleased to announce the appointment of Dr. Debra Odink to President and Chief Development Officer of the company and the addition of Dr. Shi Yin Foo to its Board of Directors.

September 1, 2022
·
2 min read
BioMidwest

UCB Showcases Strength of the Expanding Dermatology Portfolio at the 31st EADV Congress

UCB, a global biopharmaceutical company, announced that it will present 20 abstracts across its dermatology portfolio at the 31st European Academy of Dermatology and Venereology Congress in Milan, Italy, September 7-10.

September 1, 2022
·
21 min read